4D MOLECULAR THERAPEUTICS IN (FDMT) Stock Earnings & Estimates
NASDAQ:FDMT - US35104E1001 - Common Stock
6.33 USD
-0.14 (-2.16%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.13M -82.65% | 20.723M 562.08% | 37K -99.82% | 3.708M 9,921.62% | 3.206M -13.54% | 4.69M 46.29% | 19.431M 314.31% | 102.53M 427.66% | 229.92M 124.25% | 442.26M 92.35% | 727.02M 64.39% | |
| EBITDA YoY % growth | -107.63M -54.18% | -107.118M 0.48% | -181.136M -69.10% | -231.072M -27.57% | -268.129M -16.04% | -292.712M -9.17% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -110.03M -54.25% | -112.867M -2.58% | -187.841M -66.43% | -238.129M -26.77% | -258.07M -8.37% | -288.457M -11.77% | -395.005M -36.94% | -385.072M 2.51% | -309.556M 19.61% | -158.309M 48.86% | 64.91M 141.00% | |
| Operating Margin | -3,515.34% | -544.65% | -507,678.38% | -6,422.04% | -8,049.59% | -6,150.46% | -2,032.86% | -375.57% | -134.64% | -35.80% | 8.93% | |
| EPS YoY % growth | -3.32 -29.69% | -2.64 20.48% | -2.98 -12.88% | -3.72 -24.97% | -3.85 -3.44% | -4.04 -4.77% | -4.64 -15.08% | -4.35 6.37% | -3.42 21.34% | -1.67 51.19% | 0.80 147.66% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.00 -26.61% | -0.91 -1.03% | -0.99 -15.05% | -0.93 5.29% | -0.70 29.63% | -0.69 23.72% |
| Revenue Q2Q % growth | 293.617K 9,687.24% | 3.304M 330,300.00% | 14.28K 2.00% | 2.55K -83.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | -63.046M -36.43% | -64.444M -30.42% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -62.787M -22.79% | -64.012M -14.07% | -65.761M -22.64% | -68.845M -15.79% | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.98 -55.56% | -0.89 | -0.09 | -9.71% |
| Q1 2025 Q2Q % growth | -0.86 -30.30% | -0.88 | 0.02 | 2.21% |
| Q4 2024 Q2Q % growth | -0.90 -20.00% | -0.83 | -0.07 | -7.88% |
| Q3 2024 Q2Q % growth | -0.79 -229.17% | -0.72 | -0.07 | -10.47% |
| Q2 2024 Q2Q % growth | -0.63 18.18% | -0.72 | 0.09 | 12.21% |
| Q1 2024 Q2Q % growth | -0.66 25.00% | -0.76 | 0.10 | 13.06% |
| Q4 2023 Q2Q % growth | -0.75 10.71% | -0.76 | 0.01 | 0.80% |
| Q3 2023 Q2Q % growth | -0.24 69.62% | -0.61 | 0.37 | 60.37% |
| Q2 2023 Q2Q % growth | -0.77 11.49% | -0.82 | 0.05 | 6.57% |
| Q1 2023 Q2Q % growth | -0.88 -7.32% | -0.91 | 0.03 | 3.50% |
| Q4 2022 Q2Q % growth | -0.84 1.18% | -0.80 | -0.04 | -4.77% |
| Q3 2022 Q2Q % growth | -0.79 3.66% | -0.93 | 0.14 | 15.12% |
| Q2 2022 Q2Q % growth | -0.87 -210.71% | -0.87 | 0.00 | -0.35% |
| Q1 2022 Q2Q % growth | -0.82 -34.43% | -0.83 | 0.01 | 0.75% |
| Q4 2021 Q2Q % growth | -0.85 63.98% | -0.88 | 0.03 | 3.10% |
| Q3 2021 Q2Q % growth | -0.82 | -0.82 | 0.00 | 0.13% |
| Q2 2021 Q2Q % growth | -0.28 | -0.69 | 0.41 | 59.63% |
| Q1 2021 Q2Q % growth | -0.61 | -1.12 | 0.51 | 45.63% |
| Q4 2020 Q2Q % growth | -2.36 | -0.67 | -1.69 | -250.56% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 15K 200.00% | 381.623K | -366.623K | -96.07% |
| Q1 2025 Q2Q % growth | 14K -50.00% | 390.221K | -376.221K | -96.41% |
| Q4 2024 Q2Q % growth | 1K -100.00% | 1.747M | -1.746M | -99.94% |
| Q3 2024 Q2Q % growth | 3K -99.99% | 569.456K | -566.456K | -99.47% |
| Q2 2024 Q2Q % growth | 5K -97.91% | 1.337M | -1.332M | -99.63% |
| Q1 2024 Q2Q % growth | 28K -90.60% | 800.7K | -772.7K | -96.50% |
| Q4 2023 Q2Q % growth | 20.723M 1,557.84% | 2.104M | 18.619M | 884.93% |
| Q3 2023 Q2Q % growth | 20.204M 3,940.80% | 8.19M | 12.014M | 146.69% |
| Q2 2023 Q2Q % growth | 239K 49.38% | 865.297K | -626.297K | -72.38% |
| Q1 2023 Q2Q % growth | 298K -75.57% | 1.049M | -751K | -71.59% |
| Q4 2022 Q2Q % growth | 1.25M 1,288.89% | 3.066M | -1.816M | -59.23% |
| Q3 2022 Q2Q % growth | 500K -63.50% | 893.775K | -393.775K | -44.06% |
| Q2 2022 Q2Q % growth | 160K -98.90% | 873.12K | -713.12K | -81.67% |
| Q1 2022 Q2Q % growth | 1.22M -39.00% | 775.2K | 444.8K | 57.38% |
| Q4 2021 Q2Q % growth | 90K 109.18% | 918K | -828K | -90.20% |
| Q3 2021 Q2Q % growth | 1.37M -90.61% | 178.5K | 1.192M | 667.51% |
| Q2 2021 Q2Q % growth | 14.58M | 601.8K | 13.978M | 2,322.73% |
| Q4 2020 Q2Q % growth | -980K -148.28% | % | ||
| Q3 2020 Q2Q % growth | 14.589M 2,601.67% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.65% | -1.35% | -2.64% | -2.85% |
| Revenue | -22.91% | 15.14% | -14.25% | -24.06% |